艾瑞製藥 ARRY
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 9.22 | 100.52 | -1.05 | -148,106 | -146 | |
| 2025Q3 | 8.15 | 93.73 | 0.12 | 45,451 | 34 | |
| 2025Q2 | 5.90 | 70.64 | 0.18 | 46,376 | 43 | |
| 2025Q1 | 4.87 | 87.13 | 0.02 | 27,284 | 17 | |
| 2024Q4 | 6.04 | 100.92 | -0.93 | -142,346 | -127 | |
| 2024Q3 | 6.60 | 102.66 | 60.30 | -1.02 | -132,675 | -141 |
| 2024Q2 | 10.26 | 94.02 | 31.48 | 0.07 | 39,602 | 26 |
| 2024Q1 | 14.91 | 67.81 | 30.30 | -0.07 | 8,414 | 2 |
| 2023Q4 | 16.80 | 96.82 | 49.65 | 0.04 | 30,220 | 19 |
| 2023Q3 | 22.19 | 95.16 | 43.45 | 0.06 | 40,205 | 19 |
| 2023Q2 | 22.60 | 102.23 | 44.19 | 0.35 | 96,241 | 61 |
| 2023Q1 | 21.88 | 104.28 | 217.93 | 0.11 | 47,458 | 26 |
| 2022Q4 | 19.33 | 89.59 | -0.11 | 16,349 | -5 | |
| 2022Q3 | 16.58 | 38.24 | 0.19 | 26,127 | 45 | |
| 2022Q2 | 11.01 | 73.10 | -0.12 | -5,725 | -1 | |
| 2022Q1 | 11.27 | 116.72 | -0.25 | -32,161 | -22 | |
| 2021Q4 | 15.69 | 98.00 | -0.25 | -20,012 | -22 | |
| 2021Q3 | 18.52 | 97.62 | -0.25 | -12,162 | -22 | |
| 2021Q2 | 15.60 | 103.72 | -0.05 | 3,398 | -2 | |
| 2021Q1 | 29.82 | 100.60 | 0.04 | 13,053 | 3 |